Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
CardioKinetix
company
About
CardioKinetix is a medical device company offering the Parachutem, a catheter-based treatment for heart failure.
- 11 - 50
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $23M
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$37.50M
CardioKinetix has raised a total of
$37.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 1, 2013 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 1, 2013 | Series E | $23M | 1 | — | — | Detail |
| Jul 15, 2008 | Series C | $14.50M | 1 |
Cutlass Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
CardioKinetix is funded by 2 investors.
Cutlass Capital
and H&Q Healthcare Investors
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cutlass Capital
|
Yes | Series C |
|
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
